mRNA Vaccines and Therapeutics Market Size, Share, Growth, and Industry Analysis, By Types (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases), Applications (Hospitals & Clinics, Research Organization), Regional Insights and Forecast to 2033

Detailed TOC of Global mRNA Vaccines and Therapeutics Industry Research Report 2025, Competitive Landscape, Market Size, Regional Status and Prospect

Table of Content

1 mRNA Vaccines and Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccines and Therapeutics Market
1.2 mRNA Vaccines and Therapeutics Market Segment by Type
1.2.1 Global mRNA Vaccines and Therapeutics Market Sales Volume and CAGR (%) Comparison by Type (2018-2033)
1.3 Global mRNA Vaccines and Therapeutics Market Segment by Application
1.3.1 mRNA Vaccines and Therapeutics Market Consumption (Sales Volume) Comparison by Application (2018-2033)
1.4 Global mRNA Vaccines and Therapeutics Market, Region Wise (2018-2033)
1.4.1 Global mRNA Vaccines and Therapeutics Market Size (Revenue) and CAGR (%) Comparison by Region (2018-2033)
1.4.2 United States mRNA Vaccines and Therapeutics Market Status and Prospect (2018-2033)
1.4.3 Europe mRNA Vaccines and Therapeutics Market Status and Prospect (2018-2033)
1.4.4 China mRNA Vaccines and Therapeutics Market Status and Prospect (2018-2033)
1.4.5 Japan mRNA Vaccines and Therapeutics Market Status and Prospect (2018-2033)
1.4.6 India mRNA Vaccines and Therapeutics Market Status and Prospect (2018-2033)
1.4.7 Southeast Asia mRNA Vaccines and Therapeutics Market Status and Prospect (2018-2033)
1.4.8 Latin America mRNA Vaccines and Therapeutics Market Status and Prospect (2018-2033)
1.4.9 Middle East and Africa mRNA Vaccines and Therapeutics Market Status and Prospect (2018-2033)
1.5 Global Market Size of mRNA Vaccines and Therapeutics (2018-2033)
1.5.1 Global mRNA Vaccines and Therapeutics Market Revenue Status and Outlook (2018-2033)
1.5.2 Global mRNA Vaccines and Therapeutics Market Sales Volume Status and Outlook (2018-2033)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the mRNA Vaccines and Therapeutics Market

2 Industry Outlook
2.1 mRNA Vaccines and Therapeutics Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 mRNA Vaccines and Therapeutics Market Drivers Analysis
2.4 mRNA Vaccines and Therapeutics Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 mRNA Vaccines and Therapeutics Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on mRNA Vaccines and Therapeutics Industry Development

3 Global mRNA Vaccines and Therapeutics Market Landscape by Player
3.1 Global mRNA Vaccines and Therapeutics Sales Volume and Share by Player (2018-2025)
3.2 Global mRNA Vaccines and Therapeutics Revenue and Market Share by Player (2018-2025)
3.3 Global mRNA Vaccines and Therapeutics Average Price by Player (2018-2025)
3.4 Global mRNA Vaccines and Therapeutics Gross Margin by Player (2018-2025)
3.5 mRNA Vaccines and Therapeutics Market Competitive Situation and Trends
3.5.1 mRNA Vaccines and Therapeutics Market Concentration Rate
3.5.2 mRNA Vaccines and Therapeutics Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global mRNA Vaccines and Therapeutics Sales Volume and Revenue Region Wise (2018-2025)
4.1 Global mRNA Vaccines and Therapeutics Sales Volume and Market Share, Region Wise (2018-2025)
4.2 Global mRNA Vaccines and Therapeutics Revenue and Market Share, Region Wise (2018-2025)
4.3 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.4 United States mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.4.1 United States mRNA Vaccines and Therapeutics Market Under COVID-19
4.5 Europe mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.5.1 Europe mRNA Vaccines and Therapeutics Market Under COVID-19
4.6 China mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.6.1 China mRNA Vaccines and Therapeutics Market Under COVID-19
4.7 Japan mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.7.1 Japan mRNA Vaccines and Therapeutics Market Under COVID-19
4.8 India mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.8.1 India mRNA Vaccines and Therapeutics Market Under COVID-19
4.9 Southeast Asia mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.9.1 Southeast Asia mRNA Vaccines and Therapeutics Market Under COVID-19
4.10 Latin America mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.10.1 Latin America mRNA Vaccines and Therapeutics Market Under COVID-19
4.11 Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.11.1 Middle East and Africa mRNA Vaccines and Therapeutics Market Under COVID-19

5 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue, Price Trend by Type
5.1 Global mRNA Vaccines and Therapeutics Sales Volume and Market Share by Type (2018-2025)
5.2 Global mRNA Vaccines and Therapeutics Revenue and Market Share by Type (2018-2025)
5.3 Global mRNA Vaccines and Therapeutics Price by Type (2018-2025)
5.4 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth Rate by Type (2018-2025)
5.4.1 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth Rate of COVID Vaccines (2018-2025)
5.4.2 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth Rate of Infectious Disease Vaccines (2018-2025)
5.4.3 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth Rate of Cancer Vaccines (2018-2025)
5.4.4 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth Rate of Autoimmune Diseases (2018-2025)
5.4.5 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth Rate of Others (2018-2025)

6 Global mRNA Vaccines and Therapeutics Market Analysis by Application
6.1 Global mRNA Vaccines and Therapeutics Consumption and Market Share by Application (2018-2025)
6.2 Global mRNA Vaccines and Therapeutics Consumption Revenue and Market Share by Application (2018-2025)
6.3 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate by Application (2018-2025)
6.3.1 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate of Hospitals & Clinics (2018-2025)
6.3.2 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate of Research Organization (2018-2025)
6.3.3 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate of Others (2018-2025)

7 Global mRNA Vaccines and Therapeutics Market Forecast (2025-2033)
7.1 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast (2025-2033)
7.1.1 Global mRNA Vaccines and Therapeutics Sales Volume and Growth Rate Forecast (2025-2033)
7.1.2 Global mRNA Vaccines and Therapeutics Revenue and Growth Rate Forecast (2025-2033)
7.1.3 Global mRNA Vaccines and Therapeutics Price and Trend Forecast (2025-2033)
7.2 Global mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast, Region Wise (2025-2033)
7.2.1 United States mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast (2025-2033)
7.2.2 Europe mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast (2025-2033)
7.2.3 China mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast (2025-2033)
7.2.4 Japan mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast (2025-2033)
7.2.5 India mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast (2025-2033)
7.2.6 Southeast Asia mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast (2025-2033)
7.2.7 Latin America mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast (2025-2033)
7.2.8 Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast (2025-2033)
7.3 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue and Price Forecast by Type (2025-2033)
7.3.1 Global mRNA Vaccines and Therapeutics Revenue and Growth Rate of COVID Vaccines (2025-2033)
7.3.2 Global mRNA Vaccines and Therapeutics Revenue and Growth Rate of Infectious Disease Vaccines (2025-2033)
7.3.3 Global mRNA Vaccines and Therapeutics Revenue and Growth Rate of Cancer Vaccines (2025-2033)
7.3.4 Global mRNA Vaccines and Therapeutics Revenue and Growth Rate of Autoimmune Diseases (2025-2033)
7.3.5 Global mRNA Vaccines and Therapeutics Revenue and Growth Rate of Others (2025-2033)
7.4 Global mRNA Vaccines and Therapeutics Consumption Forecast by Application (2025-2033)
7.4.1 Global mRNA Vaccines and Therapeutics Consumption Value and Growth Rate of Hospitals & Clinics(2025-2033)
7.4.2 Global mRNA Vaccines and Therapeutics Consumption Value and Growth Rate of Research Organization(2025-2033)
7.4.3 Global mRNA Vaccines and Therapeutics Consumption Value and Growth Rate of Others(2025-2033)
7.5 mRNA Vaccines and Therapeutics Market Forecast Under COVID-19

8 mRNA Vaccines and Therapeutics Market Upstream and Downstream Analysis
8.1 mRNA Vaccines and Therapeutics Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of mRNA Vaccines and Therapeutics Analysis
8.6 Major Downstream Buyers of mRNA Vaccines and Therapeutics Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the mRNA Vaccines and Therapeutics Industry

9 Players Profiles
9.1 BioNtech
9.1.1 BioNtech Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.1.3 BioNtech Market Performance (2018-2025)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 AstraZeneca Plc
9.2.1 AstraZeneca Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.2.3 AstraZeneca Plc Market Performance (2018-2025)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Pfizer
9.3.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.3.3 Pfizer Market Performance (2018-2025)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Intellia Therapeutics
9.4.1 Intellia Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.4.3 Intellia Therapeutics Market Performance (2018-2025)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Crispr Therapeutics
9.5.1 Crispr Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.5.3 Crispr Therapeutics Market Performance (2018-2025)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Boehringer Ingelheim
9.6.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.6.3 Boehringer Ingelheim Market Performance (2018-2025)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Sangamo Therapeutics
9.7.1 Sangamo Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.7.3 Sangamo Therapeutics Market Performance (2018-2025)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 GlaxoSmithKline
9.8.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.8.3 GlaxoSmithKline Market Performance (2018-2025)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Bayer Group
9.9.1 Bayer Group Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.9.3 Bayer Group Market Performance (2018-2025)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Moderna
9.10.1 Moderna Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 mRNA Vaccines and Therapeutics Product Profiles, Application and Specification
9.10.3 Moderna Market Performance (2018-2025)
9.10.4 Recent Development
9.10.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source